Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACON
Aclarion
$2.29
-0.9%		$2.56
$1.95
▼
$12.03
$6.66M1.2471,329 shs46,432 shs
ITOC
Itonic
$0.29
-1.8%		$0.29
$0.22
▼
$1.15
$5.12M2.811.40 million shs52,150 shs
Pheton Holdings Ltd stock logo
PTHL
Pheton
$0.30
+2.8%		$0.29
$0.39
▼
$32.00
$1.98M5.41.35 million shs33,430 shs
VSee Health, Inc. stock logo
VSEE
VSee Health
$0.02
-8.9%		$0.07
$0.01
▼
$2.52
$55KN/A3.89 million shs465,419 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACON
Aclarion
-0.87%-9.13%-3.78%-35.85%-68.19%
ITOC
Itonic
-1.77%-9.18%+3.44%+5.29%+29,479,900.00%
Pheton Holdings Ltd stock logo
PTHL
Pheton
+2.81%+3.55%+9.93%+5.30%-68.41%
VSee Health, Inc. stock logo
VSEE
VSee Health
-8.88%-30.00%-81.67%-90.31%-97.65%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACON
Aclarion
$2.29
-0.9%		$2.56
$1.95
▼
$12.03
$6.66M1.2471,329 shs46,432 shs
ITOC
Itonic
$0.29
-1.8%		$0.29
$0.22
▼
$1.15
$5.12M2.811.40 million shs52,150 shs
Pheton Holdings Ltd stock logo
PTHL
Pheton
$0.30
+2.8%		$0.29
$0.39
▼
$32.00
$1.98M5.41.35 million shs33,430 shs
VSee Health, Inc. stock logo
VSEE
VSee Health
$0.02
-8.9%		$0.07
$0.01
▼
$2.52
$55KN/A3.89 million shs465,419 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACON
Aclarion
-0.87%-9.13%-3.78%-35.85%-68.19%
ITOC
Itonic
-1.77%-9.18%+3.44%+5.29%+29,479,900.00%
Pheton Holdings Ltd stock logo
PTHL
Pheton
+2.81%+3.55%+9.93%+5.30%-68.41%
VSee Health, Inc. stock logo
VSEE
VSee Health
-8.88%-30.00%-81.67%-90.31%-97.65%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aclarion, Inc. stock logo
ACON
Aclarion
2.00
Hold$7.50227.51% Upside
ITOC
Itonic
1.00
SellN/AN/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
1.00
SellN/AN/A
VSee Health, Inc. stock logo
VSEE
VSee Health
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest PTHL, ACON, ITOC, and VSEE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/2/2026
ITOC
Itonic
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/5/2026
Aclarion, Inc. stock logo
ACON
Aclarion
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E) ➝ Sell (E+)
7/21/2026
Aclarion, Inc. stock logo
ACON
Aclarion
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (E+) ➝ Sell (E)
7/17/2026
VSee Health, Inc. stock logo
VSEE
VSee Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/30/2026
Aclarion, Inc. stock logo
ACON
Aclarion
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E) ➝ Sell (E+)
6/12/2026
Aclarion, Inc. stock logo
ACON
Aclarion
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (E+) ➝ Sell (E)
6/5/2026
ITOC
Itonic
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aclarion, Inc. stock logo
ACON
Aclarion
$80K82.44N/AN/A$5.90 per share0.39
ITOC
Itonic
$520K9.67N/AN/A$0.48 per share0.61
Pheton Holdings Ltd stock logo
PTHL
Pheton
$305.22K6.47N/AN/A$0.94 per share0.32
VSee Health, Inc. stock logo
VSEE
VSee Health
$14.46M0.00N/AN/A($0.01) per share-1.54
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aclarion, Inc. stock logo
ACON
Aclarion
-$7.23M-$7.40N/AN/AN/A-10,948.81%-59.34%-56.12%11/11/2026 (Estimated)
ITOC
Itonic
-$5.10MN/AN/AN/AN/AN/AN/AN/AN/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
-$660KN/AN/AN/AN/AN/AN/AN/AN/A
VSee Health, Inc. stock logo
VSEE
VSee Health
-$14.71M-$0.37N/AN/AN/A-92.36%-11,636.34%-68.62%9/28/2026 (Estimated)

Latest PTHL, ACON, ITOC, and VSEE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
VSee Health, Inc. stock logo
VSEE
VSee Health
-$0.06-$0.06N/A-$0.06$5.20 million$1.56 million
8/6/2026Q2 2026
Aclarion, Inc. stock logo
ACON
Aclarion
-$1.05-$1.12-$0.07-$1.12$0.03 million$0.03 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aclarion, Inc. stock logo
ACON
Aclarion
N/AN/AN/AN/AN/A
ITOC
Itonic
N/AN/AN/AN/AN/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/AN/AN/AN/AN/A
VSee Health, Inc. stock logo
VSEE
VSee Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aclarion, Inc. stock logo
ACON
Aclarion
N/A
16.19
16.19
ITOC
Itonic
N/A
8.83
8.72
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/AN/AN/A
VSee Health, Inc. stock logo
VSEE
VSee Health
0.12
0.41
0.41

Institutional Ownership

CompanyInstitutional Ownership
Aclarion, Inc. stock logo
ACON
Aclarion
7.52%
ITOC
Itonic
N/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/A
VSee Health, Inc. stock logo
VSEE
VSee Health
1.01%

Insider Ownership

CompanyInsider Ownership
Aclarion, Inc. stock logo
ACON
Aclarion
0.01%
ITOC
Itonic
N/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/A
VSee Health, Inc. stock logo
VSEE
VSee Health
14.87%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aclarion, Inc. stock logo
ACON
Aclarion
72.88 million2.88 millionNot Optionable
ITOC
Itonic
N/A17.05 millionN/AN/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
116.58 millionN/AN/A
VSee Health, Inc. stock logo
VSEE
VSee Health
N/A3.60 millionN/AN/A

Recent News About These Companies

VSee Health Poised for Growth
August 27, 2026  |  accessnewswire.comA
VSee Health Shareholders Approve Reverse Split Flexibility
August 26, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/vsee-health-shareholders-approve-reverse-split-flexibility?utm_source=marketbeat.com&utm_medium=referral
VSee Health Raises Capital Through Convertible Debt Financing
July 31, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/vsee-health-raises-capital-through-convertible-debt-financing?utm_source=marketbeat.com&utm_medium=referral
VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized ...
July 30, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/ACCESS%20Newswire/3550991/vsee-enters-into-letter-of-intent-to-acquire-vertically-integrated-healthcare-commerce-platform-acquisition-valued-at-42million-would-add-over-35million-in-annualized-revenue-and-more-than-7million-in-earnings/
VSee Health signs LOI for healthcare platform acquisition target with over $35 million in annualized revenue
July 30, 2026  |  msn.comhttps://www.msn.com/en-us/money/mergers-and-acquisitions/vsee-health-signs-loi-for-healthcare-platform-acquisition-target-with-over-35-million-in-annualized-revenue/ar-AA2951VR
VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings
July 30, 2026  |  accessnewswire.comA
VSee Health: VSEE Vertically Integrated Healthcare Commerce Platform
July 29, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-07/69156534-vsee-health-vsee-vertically-integrated-healthcare-commerce-platform-200.htm
VSee Health Enters Initial Agreement to Acquire Healthcare Technology Assets
July 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/vsee-health-enters-initial-agreement-142158764.html
VSEE Vertically Integrated Healthcare Commerce Platform
July 29, 2026  |  accessnewswire.comA
VSee Health's Board Initiates Strategic Review
July 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/vsee-health-apos-board-initiates-132814507.html
VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value
July 28, 2026  |  accessnewswire.comA
VSee Health Enters Financing Settlement with Key Lenders
July 24, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/vsee-health-enters-financing-settlement-with-key-lenders?utm_source=marketbeat.com&utm_medium=referral
VSee Health Reaffirms Commitment to Minimizing Shareholder Dilution
July 22, 2026  |  accessnewswire.comA
VSee Health outlines AI-enabled enterprise infrastructure strategy for hospital operations
July 14, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/vsee-health-outlines-ai-enabled-enterprise-infrastructure-strategy-for-hospital-operations/ar-AA27TPaF
VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations
July 14, 2026  |  accessnewswire.comA
Health care facilities: Value-based care reshapes sector financials
July 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4613332-health-care-facilities-value-based-care-reshapes-sector-financials
VSee Health Sets 2026 Annual Meeting and Deadlines
July 10, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/vsee-health-sets-2026-annual-meeting-and-deadlines?utm_source=marketbeat.com&utm_medium=referral
VSee Health CEO Issues Shareholder Update as Company Focuses on iDoc TeleHealth Solutions for Revenue Growth and Profitability
July 9, 2026  |  accessnewswire.comA
VSee Health Faces Debt Default Trigger and Liquidity Risks
June 26, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/vsee-health-faces-debt-default-trigger-and-liquidity-risks?utm_source=marketbeat.com&utm_medium=referral
VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations
June 25, 2026  |  accessnewswire.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aclarion stock logo

Aclarion NASDAQ:ACON

$2.29 -0.02 (-0.87%)
Closing price 09/3/2026 03:59 PM Eastern
Extended Trading
$2.31 +0.02 (+0.92%)
As of 04:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Itonic NASDAQ:ITOC

$0.29 -0.01 (-1.77%)
Closing price 09/3/2026 04:00 PM Eastern
Extended Trading
$0.29 0.00 (-0.95%)
As of 06:54 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Pheton stock logo

Pheton NASDAQ:PTHL

$0.30 +0.01 (+2.81%)
As of 09/2/2026

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

VSee Health stock logo

VSee Health NASDAQ:VSEE

$0.02 0.00 (-8.88%)
As of 09/3/2026 03:31 PM Eastern

VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas